BMW Ventures IPO, a Rs 231.66 crore fresh issue, saw a muted response with 1.5x subscription as of September 26. QIBs led the bidding, while retail participation was nearly full. The allotment will be finalised on September 29, ahead of the October 1 listing, with a grey market premium indicating modest gains.Read More

Donald Trump’s recent actions, including H-1B visa changes and pharmaceutical tariffs, have dealt a significant blow to Indian stock markets, thwarting a nascent rebound. This has led to foreign investor sell-offs and increased US-India tensions, resetting expectations for a year-end rally and raising concerns about economic growth.Read More

Epack Prefab Tech’s Rs 504-crore IPO, subscribed 3.07 times, will finalise allotment on September 29, with listing scheduled for October 1. Investors can check allotment status via registrar Kfin Technologies or the BSE platform. QIBs and HNIs drove strong demand for the issue.Read More

Indian markets slumped as BSE 500 fell 3.3% amid Trump’s steep H-1B visa fee hike and 100% drug tariff announcement. Over 440 stocks dropped, with IT, realty, consumer and healthcare sectors hit hardest.Read More

Krishnan VR of Marcellus Investment Managers advises limiting gold and silver allocation to 8–10% despite record returns. He stresses equities as core, tactical debt addition, and selective opportunities in consumption, healthcare, insurance, and financialization themes amid stretched valuations.Read More

A handful of IPOs lined up for debut next week are indicating potential double-digit returns, with some tipped to deliver up to 20% gains on listing day.Read More

Once market favourites, TCS, Infosys, DMart, Asian Paints and HUL have delivered flat or negative returns over the past four years despite strong fundamentals.Read More

Indian equity indices extended their longest losing streak in FY26 for a sixth consecutive session, driven by new US tariffs on drugs and trucks, increased H-1B visa fees, and Accenture’s cautious outlook. This battered investor sentiment, leading to broad-based selling across sectors and a surging fear gauge. The rupee also traded near its record low.Read More

Nifty’s Pharma index saw a decline after US President Trump announced a 100 percent tariff on branded drugs from October 1. Analysts noted India’s limited exposure to patented drugs in the US market. Most Indian firms focus on generic medicines, which are not affected by the new tariff. Major Indian players also operate manufacturing facilities...Read More

Tata Capital, the financial services arm of Tata Group, is set to launch its ₹17,000-crore IPO from October 6-8, marking the country’s largest public offering since Hyundai last year. This significant issue, driven by RBI directives for NBFC transparency, will raise funds to strengthen Tier-I capital and support future lending growth. Tata Sons will remain...Read More